Update on Non-Alcoholic Steatohepatitis, An Issue of Clinics in Liver Disease: The Clinics: Internal Medicine, cartea 27-2
Editat de Zobair M. Younossien Limba Engleză Hardback – 11 apr 2023
Din seria The Clinics: Internal Medicine
- 5% Preț: 545.29 lei
- 70% Preț: 186.42 lei
- 5% Preț: 403.22 lei
- 5% Preț: 547.09 lei
- 5% Preț: 547.44 lei
- 5% Preț: 518.41 lei
- 5% Preț: 518.62 lei
- 5% Preț: 518.67 lei
- 5% Preț: 518.96 lei
- 5% Preț: 519.44 lei
- 5% Preț: 517.98 lei
- 5% Preț: 519.60 lei
- 5% Preț: 573.62 lei
- 5% Preț: 403.11 lei
- 5% Preț: 402.77 lei
- 5% Preț: 282.65 lei
- 5% Preț: 403.05 lei
- 5% Preț: 402.97 lei
- 5% Preț: 388.01 lei
- 5% Preț: 463.34 lei
- 5% Preț: 403.45 lei
- 5% Preț: 460.60 lei
- 5% Preț: 405.53 lei
- 5% Preț: 402.77 lei
- 5% Preț: 460.69 lei
- 5% Preț: 462.57 lei
- 5% Preț: 295.31 lei
- 5% Preț: 448.61 lei
- 5% Preț: 506.70 lei
- 5% Preț: 402.08 lei
- 5% Preț: 402.52 lei
- 5% Preț: 402.52 lei
- 5% Preț: 519.15 lei
- 5% Preț: 518.39 lei
- 5% Preț: 601.65 lei
- 5% Preț: 518.21 lei
- 5% Preț: 518.09 lei
- 21% Preț: 449.32 lei
- 21% Preț: 448.67 lei
- 5% Preț: 576.44 lei
- 5% Preț: 576.17 lei
- 5% Preț: 576.94 lei
- 5% Preț: 570.07 lei
- 5% Preț: 576.11 lei
- 5% Preț: 686.25 lei
- 5% Preț: 547.43 lei
- 5% Preț: 745.38 lei
- 5% Preț: 576.27 lei
- 5% Preț: 579.22 lei
Preț: 577.92 lei
Preț vechi: 608.34 lei
-5% Nou
Puncte Express: 867
Preț estimativ în valută:
110.60€ • 114.89$ • 91.87£
110.60€ • 114.89$ • 91.87£
Carte disponibilă
Livrare economică 13-27 ianuarie 25
Livrare express 27 decembrie 24 - 02 ianuarie 25 pentru 39.02 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323960564
ISBN-10: 0323960561
Pagini: 240
Dimensiuni: 152 x 229 x 28 mm
Greutate: 0.58 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine
ISBN-10: 0323960561
Pagini: 240
Dimensiuni: 152 x 229 x 28 mm
Greutate: 0.58 kg
Editura: Elsevier
Seria The Clinics: Internal Medicine
Cuprins
Nonalcoholic Fatty Liver Disease: Disease Burden and Disease Awareness
Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis
Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma
Changings and Challenges in Liver Transplantation for Nonalcoholic Fatty Liver Disease/Steatohepatitis
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Cardiovascular Diseases
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Nonhepatocellular Cancers
Update on Nonalcoholic Steatohepatitis: Sarcopenia and Nonalcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease in Asia, Africa, and Middle East Region
Nonalcoholic Fatty Liver Disease in Latin America and Australia
Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease: An Incomplete Jigsaw Puzzle
Genetic Markers Predisposing to Nonalcoholic Steatohepatitis
Role of Liver Biopsy in Clinical Trials and Clinical Management of Nonalcoholic Fatty Liver Disease
Roles of Radiological Tests in Clinical Trials and the Clinical Management of Nonalcoholic Fatty Liver Disease
Noninvasive Tests Used in Risk Stratification of Patients with Nonalcoholic Fatty Liver Disease
Current Treatment Options, Including Diet, Exercise, and Medications: The Impact on Histology
The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis
Future Treatment Options and Regimens for Nonalcoholic Fatty Liver Disease
Special Population: Lean Nonalcoholic Fatty Liver Disease
Special Population: Pediatric Nonalcoholic Fatty Liver Disease
Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease
Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic fatty liver disease
Research Priorities for Precision Medicine in Nonalcoholic fatty liver disease
Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis
Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma
Changings and Challenges in Liver Transplantation for Nonalcoholic Fatty Liver Disease/Steatohepatitis
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Cardiovascular Diseases
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Nonhepatocellular Cancers
Update on Nonalcoholic Steatohepatitis: Sarcopenia and Nonalcoholic Fatty Liver Disease
Nonalcoholic Fatty Liver Disease in Asia, Africa, and Middle East Region
Nonalcoholic Fatty Liver Disease in Latin America and Australia
Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease: An Incomplete Jigsaw Puzzle
Genetic Markers Predisposing to Nonalcoholic Steatohepatitis
Role of Liver Biopsy in Clinical Trials and Clinical Management of Nonalcoholic Fatty Liver Disease
Roles of Radiological Tests in Clinical Trials and the Clinical Management of Nonalcoholic Fatty Liver Disease
Noninvasive Tests Used in Risk Stratification of Patients with Nonalcoholic Fatty Liver Disease
Current Treatment Options, Including Diet, Exercise, and Medications: The Impact on Histology
The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis
Future Treatment Options and Regimens for Nonalcoholic Fatty Liver Disease
Special Population: Lean Nonalcoholic Fatty Liver Disease
Special Population: Pediatric Nonalcoholic Fatty Liver Disease
Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease
Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic fatty liver disease
Research Priorities for Precision Medicine in Nonalcoholic fatty liver disease